Victrex plc (LON:VCT - Get Free Report) fell 8.4% during trading on Tuesday . The company traded as low as GBX 667.62 ($9.08) and last traded at GBX 720 ($9.79). 827,259 shares changed hands during mid-day trading, an increase of 97% from the average session volume of 420,250 shares. The stock had previously closed at GBX 786 ($10.69).
Wall Street Analyst Weigh In
Several research firms recently issued reports on VCT. Deutsche Bank Aktiengesellschaft cut shares of Victrex to a "hold" rating and cut their price objective for the stock from GBX 990 ($13.46) to GBX 850 ($11.56) in a research report on Tuesday. JPMorgan Chase & Co. cut their price objective on shares of Victrex from GBX 940 ($12.78) to GBX 818 ($11.12) and set a "neutral" rating for the company in a research report on Wednesday.
Check Out Our Latest Stock Report on VCT
Victrex Stock Down 0.1%
The company has a current ratio of 4.39, a quick ratio of 1.99 and a debt-to-equity ratio of 10.93. The firm has a market capitalization of £627.20 million, a price-to-earnings ratio of 20.43, a PEG ratio of 1.92 and a beta of 0.69. The business's fifty day moving average price is GBX 800.54 and its 200 day moving average price is GBX 894.36.
Victrex (LON:VCT - Get Free Report) last released its quarterly earnings data on Monday, May 12th. The company reported GBX 22.60 ($0.31) EPS for the quarter. Victrex had a net margin of 10.81% and a return on equity of 6.67%. On average, equities analysts expect that Victrex plc will post 73.1078905 EPS for the current year.
Insider Activity
In other Victrex news, insider Dame Vivienne Cox bought 2,747 shares of the company's stock in a transaction that occurred on Tuesday, July 8th. The stock was purchased at an average price of GBX 721 ($9.80) per share, with a total value of £19,805.87 ($26,924.78). Also, insider David Thomas bought 1,158 shares of the company's stock in a transaction that occurred on Tuesday, May 13th. The shares were acquired at an average cost of GBX 846 ($11.50) per share, with a total value of £9,796.68 ($13,317.94). Corporate insiders own 1.64% of the company's stock.
About Victrex
(
Get Free Report)
Victrex plc, through its subsidiaries, engages in the manufacture and sale of polymer solutions worldwide. The company operates through two segments, Sustainable Solutions and Medical. It develops PEEK and PAEK based polymer solutions, and semi-finished and finished parts. The company also provides specialist solutions for medical device manufacturers; sells thermoplastic polymers; sustainable solutions for energy and industrial, VAR, automotive, aerospace, and electronics markets; and engages in trading activities.
Recommended Stories
Before you consider Victrex, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Victrex wasn't on the list.
While Victrex currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
